Hybrid Polyketides from a Hydractinia-Associated Cladosporium sphaerospermum SW67 and Their Putative Biosynthetic Origin

Mar Drugs. 2019 Oct 24;17(11):606. doi: 10.3390/md17110606.

Abstract

Five hybrid polyketides (1a, 1b, and 2-4) containing tetramic acid core including a new hybrid polyketide, cladosin L (1), were isolated from the marine fungus Cladosporium sphaerospermum SW67, which was isolated from the marine hydroid polyp of Hydractinia echinata. The hybrid polyketides were isolated as a pair of interconverting geometric isomers. The structure of 1 was determined based on 1D and 2D NMR spectroscopic and HR-ESIMS analyses. Its absolute configuration was established by quantum chemical electronic circular dichroism (ECD) calculations and modified Mosher's method. Tetramic acid-containing compounds are reported to be derived from a hybrid PKS-NRPS, which was also proved by analyzing our 13C-labeling data. We investigated whether compounds 1-4 could prevent cell damage induced by cisplatin, a platinum-based anticancer drug, in LLC-PK1 cells. Co-treatment with 2 and 3 ameliorated the damage of LLC-PK1 cells induced by 25 μM of cisplatin. In particular, the effect of compound 2 at 100 μM (cell viability, 90.68 ± 0.81%) was similar to the recovered cell viability of 88.23 ± 0.25% with 500 μM N-acetylcysteine (NAC), a positive control.

Keywords: Cladosporium sphaerospermum; LLC-PK1 cells; hybrid PKS-NRPS; hybrid polyketides; tetramic acid.

MeSH terms

  • Animals
  • Antineoplastic Agents / adverse effects
  • Cell Survival / drug effects
  • Cisplatin / adverse effects
  • Cladosporium / chemistry
  • Cladosporium / genetics*
  • LLC-PK1 Cells
  • Molecular Structure
  • Nuclear Magnetic Resonance, Biomolecular
  • Phylogeny
  • Polyketides / chemistry*
  • Polyketides / isolation & purification
  • Polyketides / pharmacology*
  • Pyrrolidinones / chemistry*
  • Pyrrolidinones / pharmacology*
  • Swine

Substances

  • Antineoplastic Agents
  • Polyketides
  • Pyrrolidinones
  • tetramic acid
  • Cisplatin